News Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:03 2026-02-13 pm EST			5-day change	1st Jan Change
112.68 ^USD	+1.09%		+1.67%	-10.06%

Feb. 06	Abbott Laboratories Says Late-Breaking Data Supports Safety, Efficacy of Ablation Catheters	MT
Feb. 06	Abbott Laboratories Announces New Clinical Data from Two Late-Breaking Presentations at AF Symposium in Boston	CI

All News

Feb. 06	Abbott Laboratories : Late-breaking data show positive safety outcomes and closure rates for new Abbott device designed to reduce stroke risk in non-valvular AFib patients	PU
Feb. 06	Abbott Laboratories Says Late-Breaking Data Supports Safety, Efficacy of Ablation Catheters	MT
Feb. 06	Abbott Laboratories Announces New Clinical Data from Two Late-Breaking Presentations at AF Symposium in Boston	CI
Feb. 06	Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation	PR
Feb. 04	US FDA says injuries from Abbott's recalled glucose sensors reach 860	RE
Feb. 04	Abbott recalls glucose sensors after seven deaths linked to faulty readings	RE
Feb. 04	FDA says Abott Diabetes Care removes some Freestyle Libre 3 and Freestyle Libre 3 Plus sensors	RE
Feb. 04	Abbott Laboratories Recall of FreeStyle Libre 3 Glucose Sensors Updated, FDA Says	MT
Feb. 02	Medtronic Achieves New US Regulatory Milestones for MiniMed Insulin Delivery System	MT
Feb. 02	Barclays Cuts Price Target on Abbott Laboratories to $142 From $169, Maintains Overweight Rating	MT
Jan. 30	Daiwa Securities Adjusts Abbott Laboratories PT to $113 From $136, Maintains Outperform Rating	MT
Jan. 30	Leerink Partners Adjusts Abbott Laboratories PT to $119 From $136, Maintains Market Perform Rating	MT
Jan. 30	The Fed's Next Chair: Reformist, Realist, or Rubber Stamp?
Jan. 30	German cartel office approved planned acquisition of Exact Sciences by Abbott	RE
Jan. 27	Argus Cuts Abbott Laboratories' Price Target to $140 From $150	MT
Jan. 26	Abbott Laboratories Insider Bought Shares Worth $2,013,967, According to a Recent SEC Filing	MT
Jan. 23	Abbott Laboratories' MedTech Business Sustains Momentum Amid Nutrition Weakness, UBS Says	MT
Jan. 23	Abbott Laboratories Expects H2 Growth Driven by Product Launches, Nutrition Recovery, RBC Says	MT
Jan. 23	Thousands brave bitter cold to demand ICE leave Minneapolis	RE
Jan. 23	The Market's Favorite Question Right Now: Is This a Return to Normal, or Just a Pause?
Jan. 23	Piper Sandler Adjusts Abbott Laboratories Price Target to $135 From $150, Maintains Overweight Rating	MT
Jan. 23	Oppenheimer Adjusts Abbott Laboratories Price Target to $132 From $140, Maintains Outperform Rating	MT
Jan. 23	BTIG Research Adjusts Abbott Laboratories PT to $145 From $140, Maintains Buy Rating	MT
Jan. 23	Goldman Sachs Adjusts Abbott Laboratories PT to $140 From $152, Maintains Buy Rating	MT
Jan. 23	Raymond James Adjusts Abbott Laboratories Price Target to $130 From $146, Maintains Outperform Rating	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

MotoAmerica is Changing Concussion Safety

May 15, 2025 at 12:18 pm EDT